D'AMICO, PAOLO
D'AMICO, PAOLO
Universita' degli Studi di MILANO
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
2024 L. Mazzarella, F. Giugliano, E. Nicolo, A. Esposito, E. Crimini, G. Tini, J. Uliano, C. Corti, P. D'Amico, P.T. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P.P.M. Berton Giachetti, I. Minchella, C. Belli, M. Locatelli, C. Criscitiello, G. Curigliano
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
2021 C. Reduzzi, S. Di Cosimo, L. Gerratana, R. Motta, A. Martinetti, A. Vingiani, P. D'Amico, Y. Zhang, M. Vismara, C. Depretto, G. Scaperrotta, S. Folli, G. Pruneri, M. Cristofanilli, M.G. Daidone, V. Cappelletti
Pharmacological management of male breast cancer
2020 B.A. Duso, D. Trapani, A. Marra, P. D'Amico, E. Guerini Rocco, N. Fusco, L. Mazzarella, C. Criscitiello, A. Esposito, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach
2018 C. Belli, M. Zuin, L. Mazzarella, D. Trapani, P. D'Amico, E. Guerini-Rocco, B. Achutti Duso, G. Curigliano
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
Targeting the microenvironment in solid tumors
2018 C. Belli, D. Trapani, G. Viale, P. D'Amico, B. Achutti Duso, P. Della Vigna, F. Orsi, G. Curigliano